Volume | 61,024 |
|
|||||
News | - | ||||||
Day High | 4.9243 | Low High |
|||||
Day Low | 4.56 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Prenetics Global Ltd | PRE | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.86 | 4.56 | 4.9243 | 4.97 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
255 | 61,024 | $ 4.74 | $ 289,057 | - | 2.85 - 15.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:38:22 | 1 | $ 4.6069 | USD |
Prenetics Global Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
55.76M | 12.02M | - | 276.37M | -190.45M | -15.85 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Prenetics Global News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.21 | 7.838 | 2.85 | 4.71 | 633,766 | 1.43 | 44.55% |
1 Month | 4.09 | 7.838 | 2.85 | 4.40 | 247,319 | 0.55 | 13.45% |
3 Months | 4.92 | 7.838 | 2.85 | 4.55 | 140,233 | -0.28 | -5.69% |
6 Months | 5.9985 | 7.838 | 2.85 | 4.68 | 85,494 | -1.36 | -22.65% |
1 Year | 12.225 | 15.00 | 2.85 | 8.22 | 90,980 | -7.59 | -62.04% |
3 Years | 126.00 | 131.25 | 2.85 | 27.46 | 198,952 | -121.36 | -96.32% |
5 Years | 126.00 | 131.25 | 2.85 | 27.46 | 198,952 | -121.36 | -96.32% |
Prenetics Global Description
Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and anywhere. It has operations across nine locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. The company develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing. |